Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function

NCT04059783 · clinicaltrials.gov ↗

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Gastrointestinal Disorders

Interventions

DRUG: STW5 (Iberogast®, BAY98-7411)

Sponsor

Bayer